Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest half life time in humans after IV administration.
Constraint: You must select all options from a, b, c, d, or e without using any additional words.
Options:
a.) CNCCC=C1c2ccccc2CCc2ccccc21
b.) CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O
c.) CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21
d.) CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1
e.) N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F
Answer: e
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one